Comprehensive Analysis Reveals Prognostic and Therapeutic Immunity-Related Biomarkers for Pediatric Metastatic Osteosarcoma

Comprehensive Analysis Reveals Prognostic and Therapeutic Immunity-Related Biomarkers for Pediatric Metastatic Osteosarcoma

<i>Background and Objectives:</i> Osteosarcoma, the most prevalent malignant bone tumor in children and adolescents, presents a complex pathogenesis characterized by various genetic and epigenetic alterations. This study aims to identify key differentially expressed genes (DEGs) in pedia...

Full description

Bibliographic Details
Main Authors:	Jin Yuan, Shengji Yu
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Medicina
Subjects:	pediatric metastatic osteosarcoma prognostic biomarker immunotherapy differential gene expression
Online Access:	https://www.mdpi.com/1648-9144/60/1/95

Similar Items

Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome
by: Alini Trujillo-Paolillo, et al.
Published: (2023-03-01)

Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma
by: Chao Wang, et al.
Published: (2020-12-01)

Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma
by: Aaron M. Taylor, et al.
Published: (2022-07-01)

Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma
by: Dafu Chen, et al.
Published: (2023-08-01)

Osteosarcoma immune prognostic index can indicate the nature of indeterminate pulmonary nodules and predict the metachronous metastasis in osteosarcoma patients
by: Xuanhong He, et al.
Published: (2022-07-01)

Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma
by: Longqing Li, et al.
Published: (2022-05-01)

Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration
by: Zhihao Chen, et al.
Published: (2022-02-01)

Osteosarcoma with Telangiectatic Features Metastatic to the Small Bowel
by: Geoffrey G. Herndon, et al.
Published: (2021-06-01)

Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets
by: Haiyu Shao, et al.
Published: (2022-03-01)

Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma
by: Yubao Gong, et al.
Published: (2022-07-01)

Autophagy-Related Genes and Long Noncoding RNAs Signatures as Predictive Biomarkers for Osteosarcoma Survival
by: Jian Zhang, et al.
Published: (2021-08-01)

Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma
by: Guillermo Herrador-Cañete, et al.
Published: (2022-09-01)

Metastatic osteosarcoma of craniovertebral junction with cervicalgia and torticollis an a pediatric patient
by: Valentina Baro, et al.
Published: (2021-06-01)

Identification of Prognostic and Predictive Osteosarcoma Biomarkers
by: Radoslav Zamborsky, et al.
Published: (2019-02-01)

Delay in diagnosis of primary osteosarcoma of bone in children: Have we improved in the last 15 years and what is the impact of delay on diagnosis?
by: Shinichirou Yoshida, et al.
Published: (2021-06-01)

Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis
by: Mi Li, et al.
Published: (2020-01-01)

Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma
by: Marta Zalacain, et al.
Published: (2021-03-01)

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy
by: Wang T, et al.
Published: (2022-10-01)

Multi-omics analysis reveals cuproptosis and mitochondria-based signature for assessing prognosis and immune landscape in osteosarcoma
by: Chenguang Jia, et al.
Published: (2024-01-01)

Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma
by: Xiaoyu Mao, et al.
Published: (2023-07-01)

Osteosarcoma metastasis to the orbit presenting as severe proptosis following trivial trauma
by: Amit Agrawal
Published: (2014-01-01)

PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma
by: Feng Yao, et al.
Published: (2021-07-01)

Identification of pyroptosis-related genes and long non-coding RNAs signatures in osteosarcoma
by: Jian Zhang, et al.
Published: (2022-10-01)

The role of extracelluar matrix in osteosarcoma progression and metastasis
by: Juncheng Cui, et al.
Published: (2020-09-01)

Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response
by: Dong Liu, et al.
Published: (2023-06-01)

Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma
by: Nicoletta Nastasi, et al.
Published: (2023-09-01)

Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas
by: Charlotte Nazon, et al.
Published: (2022-03-01)

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
by: Claudia Maria Hattinger, et al.
Published: (2021-06-01)

Deep Proteomic Analysis on Biobanked Paraffine-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out
by: Leticia Szadai, et al.
Published: (2021-12-01)

A Retrospective Comparative Analysis of Outcomes and Prognostic Factors in Adult and Pediatric Patients with Osteosarcoma
by: Stefano Testa, et al.
Published: (2021-12-01)

Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets
by: Zhihong Li, et al.
Published: (2017-07-01)

Comparative Shotgun Proteomics Reveals the Characteristic Protein Signature of Osteosarcoma Subtypes
by: Maram Alaa, et al.
Published: (2023-08-01)

Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
by: Tao Zhang, et al.
Published: (2020-07-01)

Recurrent spontaneous pneumothoraxes as a complication of osteosarcoma metastases: a case report
by: Mark Kleedehn, MD, et al.
Published: (2021-11-01)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
by: Huanlong Liu, et al.
Published: (2023-01-01)

Immunotherapy for osteosarcoma
by: Kenichiro Yahiro, et al.
Published: (2021-05-01)

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
by: Boyu Pan, et al.
Published: (2023-06-01)

Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma
by: Wu H, et al.
Published: (2023-01-01)

Corrigendum: Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
by: Tao Zhang, et al.
Published: (2020-11-01)

Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
by: Shengri Tian, et al.
Published: (2020-08-01)